Study of an experimental injection for chronic hepatitis b
Part of Infections clinical trials.
Doctors are testing a new injectable treatment for chronic hepatitis B. This first-in-human study checks the drug's safety and how well it works in people who are already on standard hepatitis B pills.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult who can understand and agree to the study rules.
- You are taking a standard hepatitis B pill (like entecavir or tenofovir) and have been for at least 6 months.
- Your hepatitis B virus level is low (below 90 IU/mL).
- Your liver tests (ALT, AST) are not too high (no more than 2 times the normal upper limit).
- Your kidneys are working well (confirmed by a blood test).
- You do not have severe liver scarring (cirrhosis) or liver failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new investigational drug called AHB-171 for people with chronic hepatitis B who are already stable on standard antiviral therapy. It aims to see if the drug is safe and may help control the virus better.
This study tests a new injection called AHB-137 in people with chronic hepatitis B who have never received antiviral treatment. The goal is to see if it can help reduce the hepatitis B virus in the body and improve liver health.
This trial tests a new injection called AHB-137 for people with chronic hepatitis B. It aims to see if the drug is safe and helps control the virus.
This study tests an investigational injection called TVAX-008 for people with chronic hepatitis B. It aims to see if the treatment can help clear the hepatitis B surface antigen, which may lead to a functional cure. The study is for people who have been on antiviral therapy and have well-controlled virus levels.
This trial tests an investigational drug called IB-001 to see how well it works and how safe it is. It is for healthy volunteers and people with chronic hepatitis B. The goal is to find the best dose and understand side effects.
This study tests a new drug called HH-006 to see if it can help treat chronic hepatitis B infection. Participants will be grouped by their infection level, and the study checks whether the drug is safe and works to reduce the hepatitis B virus.
Hear when a new HBV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.